XML 50 R36.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Revenue from Contracts with Customers - Disaggregation of Revenue (Details) $ in Thousands | 3 Months Ended | 9 Months Ended
--- | --- | ---
Sep. 30, 2022 USD ($) | Sep. 30, 2021 USD ($) | Sep. 30, 2022 USD ($) segment item | Sep. 30, 2021 USD ($)
Disaggregation of Revenue [Line Items] |  |  |  |
Number of operating segments | segment |  |  | 2 |
Net sales | $ 287,175 | $ 267,021 | $ 857,566 | $ 796,259
United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 164,571 | 151,505 | 482,237 | 451,648
International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 122,604 | 115,516 | $ 375,329 | 344,611
Cardiovascular |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Number of product categories | item |  |  | 4 |
Net sales | 278,949 | 259,704 | $ 832,555 | 773,002
Cardiovascular | Peripheral Intervention |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 110,698 | 101,059 | 327,426 | 299,573
Cardiovascular | Cardiac Intervention |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 86,848 | 79,813 | 257,909 | 240,203
Cardiovascular | Custom Procedural Solutions |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 45,692 | 49,435 | 141,047 | 143,492
Cardiovascular | OEM |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 35,711 | 29,397 | 106,173 | 89,734
Cardiovascular | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 156,897 | 144,764 | 458,967 | 429,927
Cardiovascular | United States | Peripheral Intervention |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 67,200 | 61,282 | 195,095 | 181,383
Cardiovascular | United States | Cardiac Intervention |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 33,194 | 30,562 | 95,652 | 93,030
Cardiovascular | United States | Custom Procedural Solutions |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 27,078 | 27,895 | 80,951 | 80,179
Cardiovascular | United States | OEM |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 29,425 | 25,025 | 87,269 | 75,335
Cardiovascular | International |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 122,052 | 114,940 | 373,588 | 343,075
Cardiovascular | International | Peripheral Intervention |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 43,498 | 39,777 | 132,331 | 118,190
Cardiovascular | International | Cardiac Intervention |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 53,654 | 49,251 | 162,257 | 147,173
Cardiovascular | International | Custom Procedural Solutions |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 18,614 | 21,540 | 60,096 | 63,313
Cardiovascular | International | OEM |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 6,286 | 4,372 | 18,904 | 14,399
Endoscopy |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 8,226 | 7,317 | 25,011 | 23,257
Endoscopy | Endoscopy Devices |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 8,226 | 7,317 | 25,011 | 23,257
Endoscopy | United States | Endoscopy Devices |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 7,674 | 6,741 | 23,270 | 21,721
Endoscopy | International | Endoscopy Devices |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | $ 552 | $ 576 | $ 1,741 | $ 1,536

X
- Definition Number of product categories. + References No definition available. + Details
Name: | mmsi_NumberOfProductCategories
Namespace Prefix: | mmsi_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 18 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599 + Details
Name: | us-gaap_NumberOfOperatingSegments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 924 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -URI https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_StatementGeographicalAxis=country_US
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=us-gaap_NonUsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=mmsi_CardiovascularSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=mmsi_PeripheralInterventionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=mmsi_CardiacInterventionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=mmsi_CustomProceduralSolutionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=mmsi_OEMMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=mmsi_EndoscopySegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=mmsi_EndoscopyDevicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |